Nemera Announces Better Drug Deposition with RetroNose
After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is presenting enhanced drug deposition results compared to classic nasal sprays with RetroNose.
ALREADY REGISTERED USER? SIGN IN now
REGISTER FOR FREE TO CONTINUE READING THIS ARTICLE
And get access to unlimited world-class packaging reporting and commentary.